Binding of the Radioligand [3H]-SCH 58261, a New Non-xanthine A2A Adenosine Receptor Antagonist, to Rat Striatal Membranes

Overview

Journal Br J Pharmacol

Publisher Wiley

Specialty Pharmacology

Date 1996 Apr 1

PMID 8730729

Citations 11

Authors

C Zocchi

E Ongini

S Ferrara

P G Baraldi

S Dionisotti

Affiliations

Soon will be listed here.

Abstract

1. The present study describes the binding to rat striatal A2A adenosine receptors of the new potent and selective antagonist radioligand, [3H]-5-amino-7-(2-phenylethyl)-2-(2-furyl)-pyrazolo[4,3-e]-1,2,4-triazol o [1,5-c] pyrimidine, [3H]-SCH 58261. 2. [3H]-SCH 58261 specific binding to rat striatal membranes ( > 90%) was saturable, reversible and dependent upon protein concentration. Saturation experiments revealed that [3H]-SCH 58261 labelled a single class of recognition sites with high affinity (Kd = 0.70 nM) and limited capacity (apparent Bmax = 971 fmol mg-1 of protein). The presence of 100 microM GTP in the incubation mixture did not modify [3H]-SCH 58261 binding parameters. 3. Competition experiments showed that [3H]-SCH 58261 binding is consistent with the labelling of A2A striatal receptors. Adenosine receptor agonists competed with the binding of 0.2 nM [3H]-SCH 58261 with the following order of potency: 2-hexynyl-5'-N-ethyl carboxamidoadenosine (2HE-NECA) > 5'-N-ethylcarboxamidoadenosine (NECA) > 2-[4-(2-carboxyethyl)-phenethylamino]-5'-N-ethylcarboxamidoadenosi ne (CGS 21680) > 2-phenylaminoadenosine (CV 1808) > R-N6-phenylisopropyladenosine (R-PIA) > N6-cyclohexyladenosine (CHA) = 2-chloro-N6-cyclopentyladenosine (CCPA) > S-N6-phenylisopropyladenosine (S-PIA). 4. Adenosine antagonists inhibited [3H]-SCH 58261 binding with the following order: 5-amino-9-chloro-2-(2-furyl)-[1,2,4]-triazolo[1,5-c] quinazoline (CGS 15943) > 5-amino-8-(4-fluorobenzyl)-2-(2-furyl)-pyrazolo [4,3-e]-1,2,4-triazolo [1,5-c] pyrimidine (8FB-PTP) = SCH 58261 > xanthine amine congener (XAC) = (E,18%-Z,82%)7-methyl-8-(3,4-dimethoxystyryl)-1,3-dipropylxanthine (KF 17837S) > 8-cyclopentyl-1,3-dipropylxanthine (DPCPX) > or = 8-phenyltheophylline (8-PT). 5. The Ki values for adenosine antagonists were similar to those labelled with the A2A agonist [3H]-CGS 21680. Affinities of agonists were generally lower. The A1-selective agonist, R-PIA, was found to be about 9 fold more potent than its stereoisomer, S-PIA, thus showing the stereoselectivity of [3H]-SCH 58261 binding. Except for 8-PT, the adenosine agonists and antagonists examined inhibited [3H]-SCH 58261 binding with Hill coefficients not significantly different from unity. 6. The present results indicate that [3H]-SCH 58261 is the first non-xanthine adenosine antagonist radioligand which directly labels A2A striatal receptors. High receptor affinity, good selectivity and very low non-specific binding make [3H]-SCH 58261 an excellent probe for studying the A2A adenosine receptor subtype in mammalian brain.

Citing Articles

Targets of Immune Escape Mechanisms in Cancer: Basis for Development and Evolution of Cancer Immune Checkpoint Inhibitors.

Dutta S, Ganguly A, Chatterjee K, Spada S, Mukherjee S Biology (Basel). 2023; 12(2).

PMID: 36829496 PMC: 9952779. DOI: 10.3390/biology12020218.

Adenosine-A2A Receptor Pathway in Cancer Immunotherapy.

Sun C, Wang B, Hao S Front Immunol. 2022; 13:837230.

PMID: 35386701 PMC: 8977492. DOI: 10.3389/fimmu.2022.837230.

Effects of intra-accumbal or intra-prefrontal cortex microinjections of adenosine 2A receptor ligands on responses to cocaine reward and seeking in rats.

Wydra K, Suder A, Frankowska M, Borroto Escuela D, Fuxe K, Filip M Psychopharmacology (Berl). 2018; 235(12):3509-3523.

PMID: 30426181 PMC: 6267142. DOI: 10.1007/s00213-018-5072-8.

BDNF-induced presynaptic facilitation of GABAergic transmission in the hippocampus of young adults is dependent of TrkB and adenosine A2A receptors.

Colino-Oliveira M, Rombo D, Dias R, Ribeiro J, Sebastiao A Purinergic Signal. 2016; 12(2):283-94.

PMID: 26897393 PMC: 4854840. DOI: 10.1007/s11302-016-9502-y.

Functional efficacy of adenosine A₂A receptor agonists is positively correlated to their receptor residence time.

Guo D, Mulder-Krieger T, IJzerman A, Heitman L Br J Pharmacol. 2012; 166(6):1846-59.

PMID: 22324512 PMC: 3402809. DOI: 10.1111/j.1476-5381.2012.01897.x.

References

van Calker D, Muller M, Hamprecht B . Adenosine regulates via two different types of receptors, the accumulation of cyclic AMP in cultured brain cells. J Neurochem. 1979; 33(5):999-1005. DOI: 10.1111/j.1471-4159.1979.tb05236.x. View

Luthin D, Olsson R, Thompson R, Sawmiller D, Linden J . Characterization of two affinity states of adenosine A2a receptors with a new radioligand, 2-[2-(4-amino-3-[125I]iodophenyl)ethylamino]adenosine. Mol Pharmacol. 1995; 47(2):307-13. View

Munson P, Rodbard D . Ligand: a versatile computerized approach for characterization of ligand-binding systems. Anal Biochem. 1980; 107(1):220-39. DOI: 10.1016/0003-2697(80)90515-1. View

Yeung S, Green R . [3H]5'-N-ethylcarboxamide adenosine binds to both Ra and Ri adenosine receptors in rat striatum. Naunyn Schmiedebergs Arch Pharmacol. 1984; 325(3):218-25. DOI: 10.1007/BF00495947. View

Bruns R, Lu G, Pugsley T . Characterization of the A2 adenosine receptor labeled by [3H]NECA in rat striatal membranes. Mol Pharmacol. 1986; 29(4):331-46. View

Williams M, Francis J, Ghai G, BRAUNWALDER A, PSYCHOYOS S, Stone G . Biochemical characterization of the triazoloquinazoline, CGS 15943, a novel, non-xanthine adenosine antagonist. J Pharmacol Exp Ther. 1987; 241(2):415-20. View

Bruns R, Fergus J, Badger E, Bristol J, Santay L, Hays S . PD 115,199: an antagonist ligand for adenosine A2 receptors. Naunyn Schmiedebergs Arch Pharmacol. 1987; 335(1):64-9. DOI: 10.1007/BF00165038. View

Stiles G, Jacobson K . A new high affinity, iodinated adenosine receptor antagonist as a radioligand/photoaffinity crosslinking probe. Mol Pharmacol. 1987; 32(1):184-8. PMC: 3478951. View

GILMAN A . G proteins: transducers of receptor-generated signals. Annu Rev Biochem. 1987; 56:615-49. DOI: 10.1146/annurev.bi.56.070187.003151. View

10.

Ramkumar V, Stiles G . Reciprocal modulation of agonist and antagonist binding to A1 adenosine receptors by guanine nucleotides is mediated via a pertussis toxin-sensitive G protein. J Pharmacol Exp Ther. 1988; 246(3):1194-200. View

11.

Jarvis M, Schulz R, Hutchison A, Do U, Sills M, Williams M . [3H]CGS 21680, a selective A2 adenosine receptor agonist directly labels A2 receptors in rat brain. J Pharmacol Exp Ther. 1989; 251(3):888-93. View

12.

Klotz K, Keil R, Zimmer F, Schwabe U . Guanine nucleotide effects on 8-cyclopentyl-1,3-[3H]dipropylxanthine binding to membrane-bound and solubilized A1 adenosine receptors of rat brain. J Neurochem. 1990; 54(6):1988-94. DOI: 10.1111/j.1471-4159.1990.tb04902.x. View

13.

Schiemann W, Walther J, Buxton I . On the ability of endogenous adenosine to regulate purine nucleoside receptor binding of antagonists in smooth muscle membranes. J Pharmacol Exp Ther. 1990; 255(2):886-92. View

14.

Jarvis M, Williams M, Do U, Sills M . Characterization of the binding of a novel nonxanthine adenosine antagonist radioligand, [3H]CGS 15943, to multiple affinity states of the adenosine A1 receptor in the rat cortex. Mol Pharmacol. 1991; 39(1):49-54. View

15.

Nanoff C, Jacobson K, Stiles G . The A2 adenosine receptor: guanine nucleotide modulation of agonist binding is enhanced by proteolysis. Mol Pharmacol. 1991; 39(2):130-5. PMC: 3463105. View

16.

Ji X, Stiles G, van Galen P, Jacobson K . Characterization of human striatal A2-adenosine receptors using radioligand binding and photoaffinity labeling. J Recept Res. 1992; 12(2):149-69. PMC: 3429337. DOI: 10.3109/10799899209074789. View

17.

Shimada J, Suzuki F, Nonaka H, Ishii A, Ichikawa S . (E)-1,3-dialkyl-7-methyl-8-(3,4,5-trimethoxystyryl)xanthines: potent and selective adenosine A2 antagonists. J Med Chem. 1992; 35(12):2342-5. DOI: 10.1021/jm00090a027. View

18.

Cristalli G, Eleuteri A, Vittori S, Volpini R, Lohse M, Klotz K . 2-Alkynyl derivatives of adenosine and adenosine-5'-N-ethyluronamide as selective agonists at A2 adenosine receptors. J Med Chem. 1992; 35(13):2363-8. DOI: 10.1021/jm00091a003. View

19.

Johansson B, Parkinson F, Fredholm B . Effects of mono- and divalent ions on the binding of the adenosine analogue CGS 21680 to adenosine A2 receptors in rat striatum. Biochem Pharmacol. 1992; 44(12):2365-70. DOI: 10.1016/0006-2952(92)90681-8. View

20.

Dionisotti S, Zocchi C, Varani K, Borea P, Ongini E . Effects of adenosine derivatives on human and rabbit platelet aggregation. Correlation of adenosine receptor affinities and antiaggregatory activity. Naunyn Schmiedebergs Arch Pharmacol. 1992; 346(6):673-6. DOI: 10.1007/BF00168741. View